OtherArticle
Infigratinib is a Reversible Inhibitor and Mechanism-based Inactivator of Cytochrome P450 3A4
Lloyd Wei Tat Tang, Jian Wei Teng, Ravi Kumar Verma, Siew Kwan Koh, Lei Zhou, Mei Lin Go, Hao Fan and Eric Chun Yong Chan
Drug Metabolism and Disposition August 2, 2021, DMD-AR-2021-000508; DOI: https://doi.org/10.1124/dmd.121.000508
Lloyd Wei Tat Tang
1Pharmacy, National University of Singapore, Singapore
Jian Wei Teng
2National University of Singapore, Singapore
Ravi Kumar Verma
3Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR), Singapore
Siew Kwan Koh
4Singapore Eye Research Institute, Singapore
Lei Zhou
4Singapore Eye Research Institute, Singapore
Mei Lin Go
2National University of Singapore, Singapore
Hao Fan
3Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR), Singapore
Eric Chun Yong Chan
1Pharmacy, National University of Singapore, Singapore
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherArticle
Inhibition and Inactivation of CYP3A4 by Infigratinib
Lloyd Wei Tat Tang, Jian Wei Teng, Ravi Kumar Verma, Siew Kwan Koh, Lei Zhou, Mei Lin Go, Hao Fan and Eric Chun Yong Chan
Drug Metabolism and Disposition August 2, 2021, DMD-AR-2021-000508; DOI: https://doi.org/10.1124/dmd.121.000508
OtherArticle
Inhibition and Inactivation of CYP3A4 by Infigratinib
Lloyd Wei Tat Tang, Jian Wei Teng, Ravi Kumar Verma, Siew Kwan Koh, Lei Zhou, Mei Lin Go, Hao Fan and Eric Chun Yong Chan
Drug Metabolism and Disposition August 2, 2021, DMD-AR-2021-000508; DOI: https://doi.org/10.1124/dmd.121.000508
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement